Vaughan David Investments LLC Abbott Laboratories Transaction History

Vaughan David Investments LLC

$3.95 Billion
Q2 2024

A detailed history of Vaughan David Investments LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Vaughan David Investments LLC holds 427,250 shares of ABT stock, worth $48 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

427,250

Previous 424,872 0.56%

Holding current value

$48 Million

Previous $48.3 Million 8.07%

% of portfolio

1.12%

Previous 1.2%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$100.73 - $112.44 $239,535 - $267,382	2,378 Added 0.56%	427,250 $44.4 Million
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $184,869 - $204,180	1,688 Added 0.4%	424,872 $48.3 Million
Q4 2023 Jan 29, 2024	BUY	$90.19 - $110.4 $412,078 - $504,417	4,569 Added 1.09%	423,184 $46.6 Million
Q3 2023 Nov 07, 2023	BUY	$95.53 - $114.62 $435,616 - $522,667	4,560 Added 1.1%	418,615 $40.5 Million
Q2 2023 Aug 02, 2023	BUY	$100.78 - $112.29 $119,021 - $132,614	1,181 Added 0.29%	414,055 $45.1 Million
Q1 2023 May 02, 2023	BUY	$96.86 - $114.01 $80,878 - $95,198	835 Added 0.2%	412,874 $41.8 Million
Q4 2022 Feb 07, 2023	SELL	$95.06 - $111.52 $923,983 - $1.08 Million	-9,720 Reduced 2.3%	412,039 $45.2 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $522,600 - $605,074	5,401 Added 1.3%	421,759 $40.8 Million
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $433,287 - $523,705	4,245 Added 1.03%	416,358 $45.2 Million
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $36,600 - $44,631	-321 Reduced 0.08%	412,113 $48.8 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $285,474 - $349,547	-2,471 Reduced 0.6%	412,434 $58 Million
Q3 2021 Nov 04, 2021	SELL	$116.66 - $129.06 $931,646 - $1.03 Million	-7,986 Reduced 1.89%	414,905 $49 Million
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $483,354 - $568,977	4,569 Added 1.09%	422,891 $49 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $927,099 - $1.09 Million	-8,518 Reduced 2.0%	418,322 $50.1 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $465,570 - $507,338	-4,434 Reduced 1.03%	426,840 $46.7 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $321,656 - $390,627	-3,510 Reduced 0.81%	431,274 $46.9 Million
Q2 2020 Aug 07, 2020	SELL	$76.57 - $98.0 $73,813 - $94,472	-964 Reduced 0.22%	434,784 $39.8 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $379,684 - $555,201	-6,044 Reduced 1.37%	435,748 $34.4 Million
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $738,700 - $822,346	-9,409 Reduced 2.09%	441,792 $38.4 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $301,580 - $327,006	-3,685 Reduced 0.81%	451,201 $37.8 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $183,511 - $214,030	2,518 Added 0.56%	454,886 $38.3 Million
Q1 2019 May 08, 2019	SELL	$66.22 - $80.06 $895,625 - $1.08 Million	-13,525 Reduced 2.9%	452,368 $36.2 Million
Q4 2018 Feb 08, 2019	SELL	$65.56 - $74.27 $90,145 - $102,121	-1,375 Reduced 0.29%	465,893 $33.7 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $764,442 - $922,208	-12,571 Reduced 2.62%	467,268 $34.3 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $668,617 - $737,953	-11,614 Reduced 2.36%	479,839 $29.3 Million
Q1 2018 May 04, 2018	BUY	$56.27 - $63.62 $107,194 - $121,196	1,905 Added 0.39%	491,453 $29.4 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $224,114 - $239,937	-4,175 Reduced 0.85%	489,548 $27.9 Million
Q3 2017 Nov 08, 2017	SELL	$48.06 - $53.64 $249,094 - $278,016	-5,183 Reduced 1.04%	493,723 $26.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	498,906	498,906 $24.3 Million

Others Institutions Holding ABT

# of Institutions

3,135

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan David Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vaughan David Investments LLC with notifications on news.

Account

Vaughan David Investments LLC Abbott Laboratories Transaction History